Imago BioSciences Toekomstige groei
Future criteriumcontroles 0/6
Imago BioSciences is forecast to grow earnings and revenue by 14% and 77.7% per annum respectively while EPS is expected to grow by 23.5% per annum.
Belangrijke informatie
14.0%
Groei van de winst
23.5%
Groei van de winst per aandeel
Biotechs winstgroei | 27.1% |
Inkomstengroei | 77.7% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Good |
Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Recent updates
Imago BioSciences (NASDAQ:IMGO) Is In A Good Position To Deliver On Growth Plans
Nov 08Imago BioSciences GAAP EPS of -$0.41 beats by $0.09
Aug 12Here's Why We're Not Too Worried About Imago BioSciences' (NASDAQ:IMGO) Cash Burn Situation
Jul 26Companies Like Imago BioSciences (NASDAQ:IMGO) Are In A Position To Invest In Growth
Apr 12We're Not Very Worried About Imago BioSciences' (NASDAQ:IMGO) Cash Burn Rate
Dec 08Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2025 | 11 | -122 | -115 | -92 | 5 |
12/31/2024 | N/A | -111 | -90 | -110 | 5 |
12/31/2023 | N/A | -88 | -73 | -83 | 6 |
12/31/2022 | N/A | -65 | -60 | N/A | 6 |
9/30/2022 | N/A | -62 | -52 | -52 | N/A |
6/30/2022 | N/A | -57 | -53 | -53 | N/A |
3/31/2022 | N/A | -52 | -44 | -44 | N/A |
12/31/2021 | N/A | -42 | -40 | -40 | N/A |
9/30/2021 | N/A | -33 | -31 | -31 | N/A |
6/30/2021 | N/A | -26 | -24 | -24 | N/A |
3/31/2021 | N/A | -21 | -20 | -20 | N/A |
12/31/2020 | N/A | -18 | -17 | -17 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: IMGO is forecast to remain unprofitable over the next 3 years.
Winst versus markt: IMGO is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: IMGO is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: IMGO is forecast to have no revenue next year.
Hoge groei-inkomsten: IMGO is forecast to have no revenue next year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if IMGO's Return on Equity is forecast to be high in 3 years time